Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/s0002-9378(16)32529-7 http://scihub22266oqcxt.onion/10.1016/s0002-9378(16)32529-7 7065062!ä!7065062 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Obstet+Gynecol 1982 ; 142 (7): 840-5 Nephropedia Template TP {{tp|p=7065062|t=1982. The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery |pdf=|usr=}}{{7065062}} gab.com Text The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery JO: Am J Obstet Gynecol http://www.kidney.de/pget.php?&tw=1&pmid=7065062 #FOAvip The efficacy of magnesium sulfate was evaluated as the primary tocolytic agent in the management of patients at risk for premature delivery. One hundred ninety-two patients determined to be 36 weeks' gestation or less were treated. One hundred seven patients (55.7%) received an additional oral beta-mimetic agent once labor was arrested. One hundred nineteen patients had intact membranes and 73 patients had ruptured membranes. Delay of delivery of 48 hours or longer was achieved in 70.6% of the patients with intact membranes and 60.2% of patients with ruptured membranes. Intervening obstetric complications, maternal morbidity, and neonatal septic and respiratory morbidity were increased in patients with ruptured membranes compared to patients with intact membranes. Magnesium sulfate is considered to be effective tocolytic agent having minimal adverse effects in managing patients at risk for premature delivery. Its use in patients with ruptured membranes, as with any tocolytic agent, remains controversial. Twit Text FOAVip The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery ????Am J Obstet Gynecol http://www.kidney.de/pget.php?&tw=1&pmid=7065062 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=7065062 #FOAvip English Wikipedia <ref>{{Cite pmid|7065062}}</ref> The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery #MMPMID7065062 Spisso KR; Harbert GM Jr; Thiagarajah S Am J Obstet Gynecol 1982[Apr]; 142 (7): 840-5 PMID7065062show ga The efficacy of magnesium sulfate was evaluated as the primary tocolytic agent in the management of patients at risk for premature delivery. One hundred ninety-two patients determined to be 36 weeks' gestation or less were treated. One hundred seven patients (55.7%) received an additional oral beta-mimetic agent once labor was arrested. One hundred nineteen patients had intact membranes and 73 patients had ruptured membranes. Delay of delivery of 48 hours or longer was achieved in 70.6% of the patients with intact membranes and 60.2% of patients with ruptured membranes. Intervening obstetric complications, maternal morbidity, and neonatal septic and respiratory morbidity were increased in patients with ruptured membranes compared to patients with intact membranes. Magnesium sulfate is considered to be effective tocolytic agent having minimal adverse effects in managing patients at risk for premature delivery. Its use in patients with ruptured membranes, as with any tocolytic agent, remains controversial. |Adolescent[MESH] |Adult[MESH] |Birth Weight[MESH] |Delivery, Obstetric[MESH] |Female[MESH] |Fetal Membranes, Premature Rupture/prevention & control[MESH] |Gestational Age[MESH] |Humans[MESH] |Infant Mortality[MESH] |Infant, Newborn[MESH] |Magnesium Sulfate/*therapeutic use[MESH] |Obstetric Labor, Premature/*prevention & control[MESH] |Parity[MESH] |Pregnancy[MESH]The use of magnesium sulfate as the primary tocolytic agent to prevent(epmc).pdf DeepDyve Pubget Overpricing